New research, led by a Virginia Tech chemist, may someday help natural-products chemists decrease by years the amount of time it takes for the development of certain types of medicinal drugs. The research by T. Daniel Crawford, associate professor of chemistry, involves computations of optical rotation angles on chiral—non-superimposable—molecules. The research titled, The Current State of ‘Ab Initio’ Calculations of Optical Rotation and Electronic Circular Dichcoism Spectra, appeared recently as the cover article in The Journal of Physical Chemistry A.
Many chiral molecules are important for medical treatment for illnesses ranging from acid-reflux to cancer. The term “chiral” means that two mirror images of a molecule cannot be superimposed onto each other. In other words, some are “left-handed” and some are “right-handed.”
“Most drugs have this handedness property,” Crawford said, “and for many of these drugs, even though both hands can cause a reaction, it is a situation where one hand does a good thing and one does a bad thing.” He used thalidomide as an example. A mixture of both hands of the drug was used in the late 1950s and early 1960s to treat morning sickness in pregnant women. Later studies revealed that, while one of the two hands acted as the desired sedative, the other hand was found to cause significant birth defects. Thalidomide was never approved by the FDA in the United States and was eventually taken off the market in Europe.
For chemists, therefore, it is often vital to determine which hand of a molecule they are using. In other words, when you have a sample of a chiral molecule, how do you distinguish between the left and right hand"
This is where a technique called polarimetry comes in to play. By shooting plane-polarized light through a sample of one hand, the chiral molecule in question will rotate to a characteristic angle either clockwise or counterclockwise, and the two hands of a chiral molecule produce opposite rotations.
“So if we figure out the direction and rotation of the light or each hand, we have a frame of reference for determining whether we have the left or right hand of a molecule,” Crawford said.
The problem with this method is that synthesizing the two hands of chiral molecules is often extremely time consuming. “It can take anywhere from weeks to years,” Crawford said.
Crawford’s research applies the theory of quantum mechanics to devise computational methods in order to eliminate having to create a synthetic molecule. “The hope is that this will allow us to calculate things like optical rotation very accurately,” he said. “So when an organic chemist has a molecule and doesn’t know if it is left- or right-handed, we can calculate that directly on the computer.”
Crawford said the ultimate goal in his research is to be able to provide organic chemists with computational tools to determine the handedness of a particular molecule they are working with. He said that such tools could speed up the drug development process by years.
Source: Virginia Tech
Related stories:
Synthetic molecules emulate enzyme behavior for the first time
When chemists want to produce a lot of a substance -- such as a newly designed drug -- they often turn to catalysts, molecules that speed chemical reactions. Many jobs require highly specialized catalysts, and finding one in just the right shape to connect with certain molecules can be difficult. Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand.
Researchers reverse key symptom of muscular dystrophy
Researchers at the University of Rochester Medical Center have identified a compound that eliminates myotonia – a symptom of muscular dystrophy – in mice. The study was published online today in the
Journal of Clinical Investigation.
Scientists watch on the atomic level how individual molecules recognize each other
The body is an almost perfect machine. For it to function properly, each individual component, that is each molecule, must reliably fulfill its specific function. Each molecule must thus “recognize” other molecules and work with them. A team of researchers from the Max Planck Institute for Solid State Research in Stuttgart, the Fraunhofer Institute in Freiburg, and King’s College in London, has now successfully filmed pairs of molecules during the recognition process. As reported to the journal
Angewandte Chemie, the shapes of the molecules change to accommodate each other.
Everything starts with recognition
A human body has more than 10 to the power of 27 molecules with about one hundred thousand different shapes and functions. Interactions between molecules determine our structure and keep us alive. Researchers at the Max Planck Institute for Solid State Research in Stuttgart in collaboration with scientists from the Fraunhofer Institute in Freiburg and the King’s Collage London have followed the interaction of only two individual molecules to show the basic mechanism underlying recognition of dipeptides.
Chemists develop new method for synthesizing anti-cancer flavonoids
Flavonoids. You’ve heard of them -- the good-for-your-health compounds found in plants that we enjoy in red wine, dark chocolate, green tea and citrus fruits. Mother Nature is an ace at making them, producing different ones by the thousands, but no chemist has figured out a good way to synthesize a special class of these chemicals in the laboratory. Until now.
Chemical switch triggers critical cell activities
The freeze-frame image of a molecular relay race, in which one enzyme passes off a protein like a baton to another enzyme, has solved a key mystery to how cells control some vital functions, according to investigators at St. Jude Children's Research Hospital. A report on this work appears in the January 14 advanced online publication issue of
Nature.
First glimpse of a key DNA repair protein at work
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
Hormone discovery points to benefits of 'home grown' fat
A hormone found at higher levels when the body produces its own "home grown" fat comes with considerable metabolic benefits, according to a report in the September 19th issue of the journal
Cell, a Cell Press publication. The newly discovered signaling molecule is the first example of a lipid-based hormone—most are made up of proteins--although the researchers said they expect it will not be the last.